HomeCompaniesTrestle Biotherapeutics

Trestle Biotherapeutics

Bioengineered kidneys for patients with kidney failure

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.
Active Founders
Ben Shepherd
Ben Shepherd
Founder
Alice Chen
Alice Chen
Founder
Trestle Biotherapeutics
Founded:2020
Batch:W21
Team Size:2
Status:
Active
Location:San Diego, CA